Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

類似資料

• The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
  著者:: He, Li-Zhen, 等
  出版事項: (2015)
• Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine
  著者:: He, Li-Zhen, 等
  出版事項: (2015)
• CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy
  著者:: Wasiuk, Anna, 等
  出版事項: (2017)
• Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
  著者:: Thomas, Lawrence J, 等
  出版事項: (2014)
• Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy
  著者:: Vitale, Laura A., 等
  出版事項: (2020)